Skip to content

Performance of Two Silicone Hydrogel Toric Contact Lenses

Multi-Center Evaluation Of Two Silicone Hydrogel Toric Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00638846
Enrollment
276
Registered
2008-03-19
Start date
2008-02-29
Completion date
2008-05-31
Last updated
2015-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vision Correction

Keywords

toric contact lenses, vision, comfort, toric fit characteristics, slit lamp findings

Brief summary

Evaluation of the clinical performance of two toric contact lenses in a 2-week, single masked (subject), daily wear, randomized, bilateral, parallel group study.

Interventions

silicone hydrogel toric lens, worn daily for 2 wks (2wks replacement)

silicone hydrogel toric lens, worn daily for 2 wks (2wks replacement)

Sponsors

Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Be between 18 and 45 years of age. * Sign Written Informed Consent (See separate document). * Be an existing successful daily wear toric soft contact lens. * Require a visual correction in both eyes (monovision or uniocular fitting is NOT allowed). * Does not require presbyopic correction (can read J1 @ normal reading distance). * Have a sphere requirement in the range -1.00 and -5.00D (-5.25D refractive) * Have refractive astigmatism between 0.75D and 2.50D in both eyes. * Achieve visual acuity of 20/30 or better in each eye with spherical distance correction. * Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having: * No amblyopia. * No evidence of lid abnormality or infection. * No conjunctival abnormality or infection. * No clinically significant slit lamp findings (i.e. stromal edema, vascularisation, infiltrates or abnormal opacities). * No other active ocular disease.

Exclusion criteria

* Requires concurrent ocular medication. * Clinically significant (Grade 3 or 4) corneal stromal haze, corneal vascularisation, tarsal abnormalities, bulbar hyperemia, limbal hyperemia, or any other abnormality of the cornea that would contraindicate contact lens wear. * Corneal staining Grade 3 in more than one region. * Has had refractive surgery. Has had eye injury/surgery within 8 weeks immediately prior to enrolment for this study. * Abnormal lacrimal secretions. * Pre-existing ocular irritation that would preclude contact lens fitting. * Keratoconus or other corneal irregularity. * Polymethyl methacrylate (PMMA) or Rigid Gas Permeable (RGP) lens wear in the previous 8 weeks * Extended lens wear in last 3 months. * Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear. * Diabetic. * Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV). * Pregnancy, lactating or planning a pregnancy at the time of enrolment. * Participation in any concurrent clinical trial or in last 60 days.

Design outcomes

Primary

MeasureTime frameDescription
Lens Orientation1 minute after insertionProportion of eyes with lens orientation within 5 degrees of optimal
Lens Stability10-15 minutes after insertionLens stability is measured as the amount of rotation induced from blink after the lens has settled.
Subjective Comfort2 weeks of lens wearSubjective comfort was derived from a weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response. \>0 = comfortable, \< 0 = uncomfortable. Combined measures from Week 1 and Week 5.

Secondary

MeasureTime frameDescription
Time to Fit Lensafter lens insertionTime required for the optometrist to fit the lens.
Subjective Lens Visionmeasured at 1 and 2 weeksA weighted combined score calculated from individual vision-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response was used to derive vision outcomes. \>0 = satisfactory vision, \< 0 = unsatisfactory vision. Analysis is performed on combined 1 week and 2 week data.
Overall Corneal StainingAfter 2 weeks useNational Eye Institute 0-3 Scale: Grade 0 = Normal, Grade 1 = Mild, superficial stippling, Grade 2 = Moderate, punctuate staining including superficial abrasion of the cornea, Grade 3 = Severe, abrasion or corneal erosion, deep corneal abrasion or recurrent erosion.

Countries

United States

Participant flow

Participants by arm

ArmCount
Senofilcon A Toric
senofilcon A toric contact lens. Analysis includes participants that completed the study.
137
Balafilcon A Toric
balafilcon A toric contact lens. Analysis includes participants that completed the study.
139
Total276

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event01
Overall Studylens issue13
Overall StudyLost to Follow-up32

Baseline characteristics

CharacteristicSenofilcon A ToricBalafilcon A ToricTotal
Age, Continuous29.81 years
STANDARD_DEVIATION 6.99
30.13 years
STANDARD_DEVIATION 7.69
29.97 years
STANDARD_DEVIATION 7.33
Gender
Female
91 participants92 participants183 participants
Gender
Male
46 participants45 participants91 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1330 / 133
serious
Total, serious adverse events
0 / 1330 / 133

Outcome results

Primary

Lens Orientation

Proportion of eyes with lens orientation within 5 degrees of optimal

Time frame: 1 minute after insertion

Population: Analysis was performed on participants who completed the study per protocol. The data represents 274 eyes that wore senofilcon A lenses and 278 eyes that wore balafilcon A lenses.

ArmMeasureValue (NUMBER)
Senofilcon A ToricLens Orientation0.77 proportion of eyes
Balafilcon A ToricLens Orientation0.66 proportion of eyes
Comparison: Alternative hypothesis is senofilcon A toric is superior to balfilcon A toric by having less degrees of rotation97.4% CI: [1.136, 1.739]Generalized Linear Model
Primary

Lens Stability

Lens stability is measured as the amount of rotation induced from blink after the lens has settled.

Time frame: 10-15 minutes after insertion

Population: Analysis was performed on participants who completed the study per protocol.

ArmMeasureValue (NUMBER)
Senofilcon A ToricLens Stability0.89 proportion of eyes
Balafilcon A ToricLens Stability0.88 proportion of eyes
Comparison: Alternative hypothesis is that senofilcon A toric is superior to balafilcon A toric by having less degrees of instability.97.4% CI: [0.624, 1.138]Generalized Linear Model
Primary

Subjective Comfort

Subjective comfort was derived from a weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response. \>0 = comfortable, \< 0 = uncomfortable. Combined measures from Week 1 and Week 5.

Time frame: 2 weeks of lens wear

Population: Analysis was performed on participants who completed the study per protocol.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Senofilcon A ToricSubjective Comfort0.1942 units on a scaleStandard Error 0.09637
Balafilcon A ToricSubjective Comfort-0.1738 units on a scaleStandard Error 0.09716
Comparison: Alternative hypothesis is that senofilcon A toric is superior to balafilcon A toric.97.4% CI: [0.07001, 0.368]Mixed Models Analysis
Secondary

Overall Corneal Staining

National Eye Institute 0-3 Scale: Grade 0 = Normal, Grade 1 = Mild, superficial stippling, Grade 2 = Moderate, punctuate staining including superficial abrasion of the cornea, Grade 3 = Severe, abrasion or corneal erosion, deep corneal abrasion or recurrent erosion.

Time frame: After 2 weeks use

Population: Analysis was performed on participants who completed the study per protocol.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Senofilcon A ToricOverall Corneal Staining0.0919 units on a scaleStandard Error 0.0178
Balafilcon A ToricOverall Corneal Staining0.1607 units on a scaleStandard Error 0.0178
Comparison: Alternative hypothesis is that senofilcon A toric is superior to balafilcon A toric by having a lower grade fo corneal staining.97.5% CI: [-0.0688, -0.0197]Mixed Models Analysis
Secondary

Subjective Lens Vision

A weighted combined score calculated from individual vision-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response was used to derive vision outcomes. \>0 = satisfactory vision, \< 0 = unsatisfactory vision. Analysis is performed on combined 1 week and 2 week data.

Time frame: measured at 1 and 2 weeks

Population: Analysis was performed on participants who completed the study per protocol.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Senofilcon A ToricSubjective Lens Vision0.1942 units on a scaleStandard Error 0.09637
Balafilcon A ToricSubjective Lens Vision-0.1738 units on a scaleStandard Error 0.09716
Comparison: Alternative hypothesis is that senofilcon A is superior to balafilcon A.97.4% CI: [0.07001, 0.368]Mixed Models Analysis
Secondary

Time to Fit Lens

Time required for the optometrist to fit the lens.

Time frame: after lens insertion

Population: Analysis was performed on participants who completed the study per protocol.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Senofilcon A ToricTime to Fit Lens6.2789 minutesStandard Error 0.2045
Balafilcon A ToricTime to Fit Lens7.4095 minutesStandard Error 0.1994
Comparison: Alternative hypothesis is that senofilcon A toric is superior to balafilcon A toric by having less time required to fit.97.5% CI: [-1.1307, -0.568]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026